We are evaluating the safety and effectiveness of tislelizumab for patients with untreated Hodgkin lymphoma who cannot undergo standard chemotherapy. This study aims to see how well this treatment works and how it is tolerated.
Health conditions and diseases that the clinical trial is designed to study and treat.
Classical Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of Reed-Sternberg cells. It can cause symptoms such as swollen lymph nodes, fever, night sweats, and unexplained weight loss.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.